2024 RX Tier List Rankings
What are the consensus rankings for RX groups? How do many of them compare to top M&A groups on the street? As I'm going through the SA recruiting process right now, any clarity would be helpful.
What are the consensus rankings for RX groups? How do many of them compare to top M&A groups on the street? As I'm going through the SA recruiting process right now, any clarity would be helpful.
| +326 | I Snuck Into UBS Office And Took A Shit On The Floor | 28 | 2d |
| +288 | Predicted 1Q 2027 Story - UBS IB blames Outlook Outage for Down Quarter | 41 | 14h |
| +269 | Houston 2026 Oil & Gas Investment Banking Rankings | 69 | 4h |
| +244 | Why leave restructuring for M&A? | 31 | 18h |
| +234 | Best Power/Renewables/Energy Teams? | 41 | 8h |
| +187 | Actual EB List | 27 | 2d |
| +182 | Incoming TPH Analysts Larping as PWP on LinkedIn | 27 | 1d |
| +39 | Embarrassed getting off at UBS train stop | 6 | 10h |
| +37 | Rogo Changing The Game | 9 | 4h |
| +30 | I built a game to help me practice fundamentals like DCF, merger models and LBOs. Roast it? | 7 | 10h |
Career Resources
From a deal flow perspective relative to headcount:
1A. EVR, PJT
1B. HL
1C. MOE, LAZ, PWP, CVP, GUGG, DUC
From an exits perspective besides gugg and Ducera they should all be relatively comparable. I don’t know people well enough at gugg and Ducera so someone else can comment. I know analysts from all these places get interviews at places like Apollo, Blackstone, KKR, etc. with relative ease. At this point it’s really more on the candidate.
Rx and m&a isn’t sn apples to apples comparison. It’s more of a apples vs pear. If you think there’s a chance you’ll consider growth oriented roles (corp dev, GE, VC) then you should do M&A. If you want to do credit, distressed, more legal oriented stuff then rx would be great
Think it should be more:
tier 1: PJT
tier 2: EVR, HL in that order
PJT has separated from the rest of the pack over the past ~18 months.
Bro what are you smoking? PJT and evercore are literally neck and neck. I don’t even work at Evercore but Look on reorg they and pjt take like 80% of the most topical deals in rx.
HL isn’t the same as those two. There have been a few times HL was once the advisor and later on Evercore/pjt/ended up being the new FA for the group they represented… that’s pretty fucking embarrassing lol
When’s the last time Ducera was on a relevant debtor side
Diebold, Yellow
What are the exits when you enter RX as an MBA associate? Do you get buyside roles at HF or are you considered a career banker? I've heard mixed opinions on it.
unfortunately the career paths might be restricted to CFO of a midwestern trucking company, hoping thats not true though. I dont know very many post MBA bankers that trasitioned to a good buyside
HL average mandate quality isn’t comparable to PJT/EVR/CVP/PWP…go down market and do some very small deals
The reality is the actual EBs have much better platforms / industry teams than HL and aren’t as willing to bottom feed for deals
idk why people hating lol. You're not wrong.
London rankings?
1) PJT
2) HL
Huge gap
3) Everyone else
What happened to the LAZ team? I thought they were good historically
https://www.wsj.com/articles/lazard-fires-top-restructuring-banker-accu…
Among other things
Where do Piper / Baird / Ray J / Miller Buckfire fit in?
Miller Buckfire was good 10 years ago, the others have non existent restructuring practices.
Miller Buckfire was good 10 years ago, the others have non existent restructuring practices.
Miller Buckfire was good 10 years ago, the others have non existent restructuring practices.
These are all good firms with strengths and weaknesses. PJT probably the premier name in the space
If you are asking from an analyst perspective who wants best exit opps, I think you put PJT EVR HL and Moelis at the top of the list
Anyone ever see movement from law to Rx? Have a family friend who's a 1st yr. associate in biglaw (V30-50) who wants to make the move, but doesnt do Rx law (does PE/M&A). Not knowledgeable on the Rx space so just curious if you guys see that move often
Velit dolor explicabo odio inventore ut beatae est. Tempore nemo nostrum explicabo. Architecto repudiandae voluptatem deserunt qui.
Odit vitae explicabo architecto perspiciatis. Ullam maxime dolores nobis repellat. Quam voluptas maxime et. Sed dolores ea iusto modi. Voluptas quo omnis qui non sint optio sequi. Asperiores enim non voluptatem porro et illo. Cum aliquid illo alias consequatur accusamus suscipit.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...
Eius explicabo suscipit voluptatum aut odit perferendis. Ut sunt voluptate ullam repudiandae quo qui quis. Facere non deserunt sint ut dolores quo placeat. Dolor ab et aspernatur vero et itaque.
Quas odio ut id est. Dolorem molestias ad qui omnis. Ut voluptatem corrupti similique ut quos similique est non. Delectus est quisquam architecto suscipit cum assumenda a. Est doloribus et consequuntur architecto soluta qui est sint. Est sint rerum quisquam iure ducimus. Error veniam accusamus tenetur inventore nisi debitis iste.
Ut enim sint ducimus neque ut minima accusamus at. Eum beatae vitae et sunt fugit provident. Et modi necessitatibus in est fugit qui iusto. Illo deserunt sed facere distinctio minima accusamus ea. Optio recusandae odit quasi vel et at optio. Quia molestiae voluptatem perspiciatis quidem fugit officiis. Tempore minima temporibus rerum ratione ut eveniet. Quis et eos id similique illum inventore quia.
Consequatur modi nemo molestiae velit provident. Qui illo placeat illo omnis soluta sunt. Consequatur sint aut voluptatem pariatur quasi. Dolores dolore nostrum illum qui. Veniam vero nostrum cum nihil sed reiciendis sit ipsum.